Clinical Trials in San Diego

Showing 3041-3060 of 7,028 trials

Topical NVN1000 for the Treatment of External Genital and Perianal Warts

NCT02462187

A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects with External Genital Warts and Perianal Warts

Genital WartsPerianal Warts

Novan, Inc.108 participantsStarted Jun 2015

Fountain Valley, California, United States • Lomita, California, United States • San Diego, California, United States +12 more locations

COMPLETEDPhase 1< 1 mile

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

This is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy and in combination with pembrolizumab; to assess safety, tolerability, pharmacokinetics, immunogenicity, and anti-tumor activity of XmAb22841 monotherapy and in combination with pembrolizumab in subjects with select advanced solid tumors.

MelanomaCervical CarcinomaPancreatic Carcinoma+20 more

Xencor, Inc.78 participantsStarted May 2019

Encinitas, California, United States • La Jolla, California, United States • La Jolla, California, United States +25 more locations

Topical NVN1000 for the Treatment of External Genital and Perianal Warts

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Find Trials by Condition in San Diego

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

OPTIMIZE IDE for the Treatment of ACS

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

The TREFOIL Concept 5 Year Clinical Investigation

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis